China approves Sinovac Biotech Covid vaccine for public use

Beijing - The CoronaVac vaccine had already been administered in China's vaccination programme.



By Reuters

Published: Sat 6 Feb 2021, 12:59 PM

Last updated: Sat 6 Feb 2021, 1:26 PM

Sinovac Biotech said on Saturday that its unit's Covid-19 vaccine has been formally approved for use by the general public by China's medical products regulator.

Prior to the approval, the CoronaVac vaccine had already been administered in China's vaccination programme mainly targeting key groups deemed to be at higher risk of exposure to the virus.


More news from coronavirus